Cargando…

Inhibition of Neutral Sphingomyelinase 2 by Novel Small Molecule Inhibitors Results in Decreased Release of Extracellular Vesicles by Vascular Smooth Muscle Cells and Attenuated Calcification

Vascular calcification (VC) is an important contributor and prognostic factor in the pathogenesis of cardiovascular diseases. VC is an active process mediated by the release of extracellular vesicles by vascular smooth muscle cells (VSMCs), and the enzyme neutral sphingomyelinase 2 (nSMase2 or SMPD3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavlic, Angelina, Poelman, Hessel, Wasilewski, Grzegorz, Wichapong, Kanin, Lux, Petra, Maassen, Cecile, Lutgens, Esther, Schurgers, Leon J., Reutelingsperger, Chris P., Nicolaes, Gerry A. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916533/ https://www.ncbi.nlm.nih.gov/pubmed/36768348 http://dx.doi.org/10.3390/ijms24032027

Ejemplares similares

Vascular Smooth Muscle Cell Neutral Sphingomyelinase 2 in the Release of Exosomes and Vascular Calcification
por: Pavlic, Angelina, et al.
Publicado: (2022)

The role of extracellular histones in COVID‐19
por: de Vries, Femke, et al.
Publicado: (2022)

PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune‐mediated disease
por: Liu, Xiaosong, et al.
Publicado: (2021)

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity
por: Ercig, Bogac, et al.
Publicado: (2021)

Histone H3 Cleavage in Severe COVID-19 ICU Patients
por: Huckriede, Joram, et al.
Publicado: (2021)

Structure-based peptide design targeting intrinsically disordered proteins: Novel histone H4 and H2A peptidic inhibitors
por: Wichapong, Kanin, et al.
Publicado: (2021)

Association of Red Blood Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio with Calcification and Cardiovascular Markers in Chronic Kidney Disease
por: Roumeliotis, Stefanos, et al.
Publicado: (2023)

Neutral Sphingomyelinase and Breast Cancer Research
por: Hwang, Sun-Yong, et al.
Publicado: (2015)

Neutral sphingomyelinase‐2 and cardiometabolic diseases
por: Sindhu, Sardar, et al.
Publicado: (2021)

Postprocessing of molecular docking poses using binding free energy calculations
por: Wichapong, Kanin, et al.
Publicado: (2012)

Osteomodulin attenuates smooth muscle cell osteogenic transition in vascular calcification
por: Skenteris, Nikolaos T., et al.
Publicado: (2022)

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
por: Lea, Simon R, et al.
Publicado: (2016)

Acid sphingomyelinase promotes SGK1-dependent vascular calcification
por: Luong, Trang Thi Doan, et al.
Publicado: (2021)

Inhibition of neutral sphingomyelinase 2 promotes remyelination
por: Yoo, Seung-Wan, et al.
Publicado: (2020)

Effects of Exogenous Recombinant APC in Mouse Models of Ischemia Reperfusion Injury and of Atherosclerosis
por: Wildhagen, Karin C. A. A., et al.
Publicado: (2014)

Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear
por: Hrdinova, Johana, et al.
Publicado: (2022)

Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane
por: Menck, Kerstin, et al.
Publicado: (2017)

The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes
por: Jaminon, Armand, et al.
Publicado: (2019)

Nicotine promotes vascular calcification via intracellular Ca(2+)-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells
por: Petsophonsakul, Ploingarm, et al.
Publicado: (2021)

Calcium Signalling in Heart and Vessels: Role of Calmodulin and Downstream Calmodulin-Dependent Protein Kinases
por: Beghi, Sofia, et al.
Publicado: (2022)

Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles
por: Schurgers, Leon J., et al.
Publicado: (2018)

Development of the BioHybrid Assay: Combining Primary Human Vascular Smooth Muscle Cells and Blood to Measure Vascular Calcification Propensity
por: Jaminon, Armand M. G., et al.
Publicado: (2021)

Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition
por: Arcidiacono, Maria Vittoria, et al.
Publicado: (2019)

Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling
por: Willems, Brecht A., et al.
Publicado: (2018)

Update – PROFILE: Early-Stage Researchers Advancing Insights on TTP through a Unique PhD Track
por: Vanhoorelbeke, Karen, et al.
Publicado: (2019)

Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients
por: Huckriede, Joram, et al.
Publicado: (2021)

Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction
por: Cogolludo, Angel, et al.
Publicado: (2009)

Neutral Sphingomyelinase in Physiological and Measles Virus Induced T Cell Suppression
por: Mueller, Nora, et al.
Publicado: (2014)

The Activity of the Neutral Sphingomyelinase Is Important in T Cell Recruitment and Directional Migration
por: Collenburg, Lena, et al.
Publicado: (2017)

Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma
por: Mühle, Christiane, et al.
Publicado: (2023)

Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity
por: Uengwetwanit, Tanaporn, et al.
Publicado: (2022)

Holotoxin A(1) Induces Apoptosis by Activating Acid Sphingomyelinase and Neutral Sphingomyelinase in K562 and Human Primary Leukemia Cells
por: Yun, Seong-Hoon, et al.
Publicado: (2018)

A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization
por: Khavandgar, Zohreh, et al.
Publicado: (2011)

The Neutral Sphingomyelinase 2 Is Required to Polarize and Sustain T Cell Receptor Signaling
por: Börtlein, Charlene, et al.
Publicado: (2018)

Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo
por: Risner, Michael L., et al.
Publicado: (2023)

Inhibition of extracellular vesicle pathway using neutral sphingomyelinase inhibitors as a neuroprotective treatment for brain injury
por: Kumar, Asit, et al.
Publicado: (2021)

Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
por: Zhu, Xiaolei, et al.
Publicado: (2022)

Molecular modeling of human neutral sphingomyelinase provides insight into its molecular interactions
por: Dinesh,, et al.
Publicado: (2011)

Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle
por: Moylan, Jennifer S., et al.
Publicado: (2014)

Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties
por: Figuera-Losada, Mariana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_slg0mn900rmnuj1boq2h364crc